iVis Technologies is pleased to announce that it has been undertaking the expansion works of its corporate headquarters since June 2022.

The production site will see its current volume doubled and an area for clinical trials and a guest house to host young researchers will also be built.

This will allow the company not only to be able to expand its production department but also to be able to become a pole of attraction for young talents, at the same time demonstrating the will of the entire iVis team to confirm itself at the top of national and international excellence in the biomedical sector.